Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Mirimus

Mirimus

Since its founding 10 years ago, Mirimus, Inc. has established itself as a leader in conducting high-volume, complex and highly effective PCR testing. This unique skillset led Mirimus to develop SalivaClear, a COVID-19 testing platform that combines saliva-based sampling, pooled testing and PCR diagnostics to improve the scalability, efficiency, cost-effectiveness and accuracy of COVID-19 testing.

Last updated on

About Mirimus

Founded

2011

Estimated Revenue

$10M-$50M

Employees

51-250

Funding / Mkt. Cap

$3M

Category

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Location

City

Brooklyn

State

New York

Country

United States

Tech Stack (62)

search